Standigm reveals novel drug discovering services using new AI technology
A novel drug discovering company based on artificial intelligence ‘Standigm(CEO Jin-Han Kim)’ announced the company selected as the next-generation pharmaceutical and biotechnology company at the ‘23th Bio-Europe,’ an international partnering conference in Berlin between the 6th and 8th was able ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.